Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Santinelli

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|November 24, 2005
Efficacy of caspofungin against Aspergillus terreusFrancesco Barchiesi, Elisabetta Spreghini, Alfredo Santinelli, et al.
Clinical Breast Cancer|August 6, 2019
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer PatientsLuca Cantini, Mirco Pistelli, Filippo Merloni, et al.
Lung Cancer (Amsterdam, Netherlands)|April 11, 2026
A multicenter prospective study of single nucleotide polymorphisms in the PDCD1 (programmed cell death 1) gene in patients with metastatic lung adenocarcinoma treated with pembrolizumabRita Chiari, Marco Russano, Giacomo Leva, et al.
Oncotarget|October 1, 2016
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sexRossana Berardi, Francesca Morgese, Alfredo Santinelli, et al.
Cancer Treatment Reviews|June 10, 2006
Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature reviewRossana Berardi, Berardi Rossana, Mario Scartozzi, et al.
Pathologica|January 5, 2024
Think "HER2" different: integrative diagnostic approaches for HER2-low breast cancerCaterina Marchiò, Carmen Criscitiello, Cristian Scatena, et al.
Analytical and Quantitative Cytology and Histology|May 8, 2008
Bayesian belief network for the Gleason patterns in prostatic adenocarcinoma: development of a diagnostic decision support system for educational purposesRodolfo Montironi, Richard Yardley Ball, David Francis Rees Griffiths, et al.
JCO Oncology Practice|October 9, 2025
Comprehensive Diagnostic and Therapeutic Approaches for Estrogen Receptor-Low Breast Cancer: A Multidisciplinary Perspective From Oncologists and PathologistsPaola Zagami, Andrea Botticelli, Isabella Castellano, et al.
Rheumatology (Oxford, England)|May 23, 2020
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Rheumatology (Oxford, England)|August 9, 2020
Corrigendum to: Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|November 24, 2005
Efficacy of caspofungin against Aspergillus terreusFrancesco Barchiesi, Elisabetta Spreghini, Alfredo Santinelli, et al.
Clinical Breast Cancer|August 6, 2019
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer PatientsLuca Cantini, Mirco Pistelli, Filippo Merloni, et al.
Lung Cancer (Amsterdam, Netherlands)|April 11, 2026
A multicenter prospective study of single nucleotide polymorphisms in the PDCD1 (programmed cell death 1) gene in patients with metastatic lung adenocarcinoma treated with pembrolizumabRita Chiari, Marco Russano, Giacomo Leva, et al.
Oncotarget|October 1, 2016
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sexRossana Berardi, Francesca Morgese, Alfredo Santinelli, et al.
Cancer Treatment Reviews|June 10, 2006
Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature reviewRossana Berardi, Berardi Rossana, Mario Scartozzi, et al.
Pathologica|January 5, 2024
Think "HER2" different: integrative diagnostic approaches for HER2-low breast cancerCaterina Marchiò, Carmen Criscitiello, Cristian Scatena, et al.
Analytical and Quantitative Cytology and Histology|May 8, 2008
Bayesian belief network for the Gleason patterns in prostatic adenocarcinoma: development of a diagnostic decision support system for educational purposesRodolfo Montironi, Richard Yardley Ball, David Francis Rees Griffiths, et al.
JCO Oncology Practice|October 9, 2025
Comprehensive Diagnostic and Therapeutic Approaches for Estrogen Receptor-Low Breast Cancer: A Multidisciplinary Perspective From Oncologists and PathologistsPaola Zagami, Andrea Botticelli, Isabella Castellano, et al.
Rheumatology (Oxford, England)|May 23, 2020
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Rheumatology (Oxford, England)|August 9, 2020
Corrigendum to: Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritisMichele Maria Luchetti, Francesco Ciccia, Chiara Avellini, et al.
Pageof 7